The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 3rd 2024
A study reveals that individuals with schizophrenia spectrum disorders experience high rates of comorbid mental health conditions and receive minimally adequate treatment.
September 26th 2024
September 20th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
FDA Cracks Down on Alcohol-Caffeine Combo Drinks
November 16th 2009The FDA has sent a letter to 30 companies warning that it hasn’t approved beverages containing both caffeine and alcohol, and that it intends to begin removing such products from store shelves in 30 days if the companies can’t explain why such products are safe and legal.
The pundits are going to have their field day with this one. "The danger [with this Bill] is that as costs continue to rise and coverage becomes less comprehensive, people will conclude that we've tried health reform and it didn't work. But the real problem will be that we didn't really try it.
Transcranial Magnetic Stimulation (TMS) Clinic Offers Noninvasive Treatment For Major Depression
November 6th 2009Committing to the promise it holds, Rush University Medical Center psychiatrists are now putting into action transcranial magnetic stimulation, the first FDA-approved, non-invasive antidepressant device-based treatment that is clinically proven for depression treatment, making them among the first to test the technique after having helped develop it.
Schizophrenia-related Gene Deletion Alters Brain's Circuit System, Development
October 19th 2009Researchers at the University of North Carolina-Chapel Hill have discovered how the 22q11 gene deletion is associated with changes in brain development that affect how the circuit system in the brain is put together.
Alcohol Use Common Among Chronic Pain Patients
October 6th 2009Professionals should educate and monitor their pain patients' use of alcohol according to a University of Florida study which found that use of alcohol as a pain management strategy was consistent across the three patient groups, ranging from 25 to 28 percent. Use was more prevalent in men and corresponded to higher income levels.
New Schizophrenia Drug Extends Time to Relapse and Treatment Discontinuation
September 21st 2009The results of a new clinical trial of the schizophrenia drug Saphris (asenapine) has shown that the drug is effective at significantly extending both the time to relapse or impending relapse and the time to treatment discontinuation.
Depression Following a Coronary Event Increases Risk of Death
September 16th 2009Patients who suffer from depression in the first several weeks after being hospitalized for a coronary event and those patients whose depression does not improve over six months are at an increased risk of death compared to coronary patients who are not depressed.